z-logo
open-access-imgOpen Access
Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients
Author(s) -
Michael J. Satlin,
Kalyan D. Chavda,
Thomas Baker,
Liang Chen,
Elena Shashkina,
Rosemary Soave,
Catherine B. Small,
Samantha E. Jacobs,
Tsiporah B. Shore,
Koen van Besien,
Lars F. Westblade,
Audrey N. Schuetz,
Vance G. Fowler,
Stephen G. Jenkins,
Thomas J. Walsh,
Barry N. Kreiswirth
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy363
Subject(s) - bacteremia , medicine , levofloxacin , enterobacteriaceae , hematopoietic stem cell transplantation , microbiology and biotechnology , colonization , hematopoietic stem cell , stem cell , transplantation , haematopoiesis , antibiotics , biology , gene , genetics , escherichia coli
Bacteremia caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) is associated with inadequate empirical therapy and substantial mortality in neutropenic patients. Strategies are needed to identify neutropenic patients at high risk of these infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom